{
    "title": "Strides Pharma to conduct trials in India for potential COVID-19 drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8342859/Strides-Pharma-conduct-trials-India-potential-COVID-19-drug.html",
    "date": "2020-05-21",
    "keywords": [
        "company",
        "drug",
        "favipiravir",
        "country",
        "bengaluru",
        "ltd",
        "thursday",
        "approval",
        "treatment",
        "covid19",
        "wednesday",
        "efficacy",
        "coronavirus",
        "bioequivalence",
        "study",
        "science",
        "controller",
        "general",
        "india",
        "executive",
        "conference",
        "call",
        "brand",
        "name",
        "unit",
        "corp",
        "use",
        "news",
        "evidence",
        "avigan",
        "disease",
        "vaccine",
        "safety",
        "spokesman",
        "statement",
        "nature",
        "announcement",
        "month",
        "pharma",
        "nod",
        "july",
        "fourthquarter",
        "loss",
        "inventory",
        "withdrawal",
        "ranitidine",
        "companys",
        "high",
        "trade",
        "afternoon",
        "gmt",
        "anuron",
        "kumar",
        "mitra",
        "editing",
        "syamnath",
        "shounak",
        "dasgupta",
        "rashmi",
        "aich"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}